Total Funding
46
40
Total FundingPost-IPO Debt raised
Growth Score
-3 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
110850
Knight Therapeutics is a specialty pharmaceutical company that focuses on acquiring and marketing prescription pharmaceuticals.
Jonathan Ross Goodman: Founder ,President & CEOPast Role: Paladin Labs, CEO
Samira Sakhia: President, Chief Executive Officer & DirectorPast Role: Paladin Labs, CFO
About the Company
Knight Therapeutics is a specialty pharmaceutical company that focuses on acquiring, in-licensing, out-licensing, marketing, and distributing innovative prescription pharmaceuticals.
